Biotech · Private company
Frontier Science & Technology Research Foundation, Inc.
Track this companyFree. Adds Frontier Science & Technology Research Foundation, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials73 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials7
- CASCADE: Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIVPHASE2 · WITHDRAWN · started Apr 30, 2026ClinicalTrials.gov NCT07090174 · fetched Nov 12, 2026
- Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening AccuraciesENROLLING_BY_INVITATION · started Nov 12, 2024ClinicalTrials.gov NCT06144229 · fetched Nov 12, 2026
- Long-Term Outcomes of Children With Congenital CMV in New York StateRECRUITING · started Feb 1, 2024ClinicalTrials.gov NCT06226558 · fetched Nov 12, 2026
- A Long Term Study to Find Out if Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular DiseasePHASE2 · TERMINATED · started Dec 7, 2018ClinicalTrials.gov NCT03714815 · fetched Nov 12, 2026
- A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast CancerPHASE3 · TERMINATED · started Aug 2, 2018ClinicalTrials.gov NCT03498716 · fetched Nov 12, 2026
- Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast CancerPHASE3 · ACTIVE_NOT_RECRUITING · started Apr 22, 2014ClinicalTrials.gov NCT02032823 · fetched Nov 12, 2026
- Self Administered Cognitive Behavior Therapy for Irritable Bowel SyndromeNA · COMPLETED · started Aug 1, 2010ClinicalTrials.gov NCT00738920 · fetched Nov 12, 2026